Last Updated: Feb 10, 2025
The U.S. Food and Drug Administration (FDA) is
alerting patients of a safety concern regarding diabetes devices, such as
continuous glucose monitors (CGMs), insulin pumps and automated insulin dosing
systems, that rely on a smartphone to deliver critical safety alerts. Users of
these smartphone-compatible diabetes devices can configure alert settings, such
as which alerts to receive, how often and how the alerts are delivered through
the app on their phone.
Read more.